IP Verse

Zika Virus Vaccine - EP3393510

The patent EP3393510 was granted to Valneva Austria on Feb 22, 2023. The application was originally filed on Dec 23, 2016 under application number EP16828746A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3393510

VALNEVA AUSTRIA
Application Number
EP16828746A
Filing Date
Dec 23, 2016
Status
Granted And Under Opposition
Jan 20, 2023
Grant Date
Feb 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDNov 21, 2023MAIWALDADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTCN105749268
INTERNATIONAL-SEARCH-REPORTUS6309650
INTERNATIONAL-SEARCH-REPORTUS8765148
INTERNATIONAL-SEARCH-REPORTWO2016145149
INTERNATIONAL-SEARCH-REPORTWO2017009873
OPPOSITIONCN105749268
OPPOSITIONUS11219681
OPPOSITIONUS8765148
OPPOSITIONWO2004084938
OPPOSITIONWO2013083726
OPPOSITIONWO2016145149
OPPOSITIONWO2017009873

Non-Patent Literature (NPL) Citations (22) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Current Zika Product Pipeline", World Health Organization, URL: http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf, (20160531), XP055276663-
OPPOSITION- Anonymous, "Zika Virus, Microcephaly and Guillain-Barré Syndrome Situation Report", WHO Situation Report, WHO, (20160317), pages 1 - 13, WHO Situation Report, URL: https://reliefweb.int/report/world/who-zika-virus-microcephaly-and-guillain-barr-syndrome-situation-report-17-march-2016, (20240325), XP093145300-
OPPOSITION- Anonymous , "Zika virus strain H/PF/2013 polyprotein gene, complete cds", Nucleotide , NCBI, XP093145292-
OPPOSITION- Hombach, J. ; Solomon, T. ; Kurane, I. ; Jacobson, J. ; Wood, D., "Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20051101), vol. 23, no. 45, ISSN 0264-410X, pages 5205 - 5211, XP027651994-
OPPOSITION- N. N., "VALNEVA AUSTRIA GMBH IXIARO HIGHLIGHTS OF PRESCRIBING INFORMATION", (20180901), (20210122), XP055767985-
OPPOSITION- Pellerin Cheryl , "Walter Reed Scientists Test Zika Vaccine Candidate", DOD News, (20160609), pages 1 - 6, DOD News, URL: https://www.defense.gov/News/News-Stories/Article/Article/795226/walter-reed-scientists-test-zika-vaccine-candidate/, (20240815), XP093195461-
OPPOSITION- Sanders Barbara, Koldijk Martin, Schuitemaker Hanneke, "2.1 Introduction to Vaccines Based on Inactivated Viruses", Vaccine Analysis: Strategies, Principles, and Control, Berlin, Heidelberg, Springer Berlin Heidelberg, (20150101), pages 45 - 49, doi:10.1007/978-3-662-45024-6_2, ISBN 978-3-662-45024-6, XP093145240
OPPOSITION- Robert Schlegl, Michael Weber, Jürgen Wruss, Donald Low, Kirsten Queen, Shaun Stilwell, Erik B. Lindblad, Michael Möhlen, "Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151101), vol. 33, no. 44, doi:10.1016/j.vaccine.2015.05.103, ISSN 0264-410X, pages 5989 - 5996, XP055315021
OPPOSITION- Enfissi Antoine; Codrington John; Roosblad Jimmy; Kazanji Mirdad; Rousset Dominique, "Zika virus genome from the Americas", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20160108), vol. 387, no. 10015, doi:10.1016/S0140-6736(16)00003-9, ISSN 0140-6736, pages 227 - 228, XP029389195
OPPOSITION- Srivastava, A.K. Putnak, J.R. Lee, S.H. Hong, S.P. Moon, S.B. Barvir, D.A. Zhao, B. Olson, R.A. Kim, S.-O. Yoo, W.-D. Towle, A.C. Vaughn, D.W. Innis, B.L. Eckels, K.H., "A purified inactivated Japanese encephalitis virus vaccine made in vero cells", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20010814), vol. 19, no. 31, doi:10.1016/S0264-410X(01)00208-0, ISSN 0264-410X, pages 4557 - 4565, XP004296120
OPPOSITION- Rafael A. Larocca, Peter Abbink, Jean Pierre S. Peron, Paolo M. De A. Zanotto, M. Justin Iampietro, Alexander Badamchi-Zadeh, Michael Boyd, David Ng’ang’a, Marinela Kirilova, Ramya Nityanandam, Noe B. Mercado, Zhenfeng Li, Edward T. Moseley, Christine A. Bricault, Erica N. Borducchi, Patricia B. Giglio, David Jetton, George Neubauer, Joseph P. Nkolola, Lori F. Maxfield, Rafael A. De La Barrera, Richard G. Jarman, Kenneth H. Eckels, Nelson L. Michael, Stephen J. Thomas, Dan H. Barouch, "Vaccine protection against Zika virus from Brazil", Nature, (20160801), vol. 536, no. 7617, doi:10.1038/nature18952, pages 474 - 478, XP055550329
OPPOSITION- Petersen Lyle R., Jamieson Denise J., Powers Ann M., Honein Margaret A., "Zika Virus", The New England journal of medicine, Massachusetts Medical Society, US, US , (20160421), vol. 374, no. 16, doi:10.1056/NEJMra1602113, ISSN 0028-4793, pages 1552 - 1563, XP093145258
OPPOSITION- Zhang Xianwen, Xie Xuping, Zou Jing, Xia Hongjie, Shan Chao, Chen Xinwen, Shi Pei-Yong, "Genetic and biochemical characterizations of Zika virus NS2A protein", Emerging Microbes & Infections, NPG, (20190101), vol. 8, no. 1, doi:10.1080/22221751.2019.1598291, ISSN 2222-1751, pages 585 - 602, XP093145254
OPPOSITION- Robert Putnak, David A. Barvir, Jeanne M. Burrous, Doria R. Dubois, Valerie M. D'Andrea, Charles H. Hoke, Jerald C. Sadoff, Kenneth H. Eckels, "Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys ", Journal of Infectious Diseases, University of Chicago Press, US, US , (19961201), vol. 174., no. 06., doi:10.1093/infdis/174.6.1176, ISSN 0022-1899, pages 1176 - 1184, XP000952637
OPPOSITION- J. Cohen, "The race for a Zika vaccine is on", Science, American Association for the Advancement of Science, US, US , (20160205), vol. 351, no. 6273, doi:10.1126/science.351.6273.543, ISSN 0036-8075, pages 543 - 544, XP055360676
OPPOSITION- Abbink Peter, Larocca Rafael A., De La Barrera Rafael A., Bricault Christine A., Moseley Edward T., Boyd Michael, Kirilova Marinela, Li Zhenfeng, Ng’ang’a David, Nanayakkara Ovini, Nityanandam Ramya, Mercado Noe B., Borducchi Erica N., Agarwal Arshi, Brinkman Amanda L., Cabral Crystal, Chandrashekar Abishek, Giglio Patricia B., Jetton David, Jimenez Jessica, Lee Benjamin C., Mojta Shanell, Molloy Katherine, Shetty Mayuri, Neubauer George H., Stephenson Kathryn E., Peron Jean Pierre S., Zanotto Paolo M. De A., Misamore Johnathan, Finneyfrock Brad, Lewis Mark G., Alter Galit, Modjarrad Kayvon, Jarman Richard G., Eckels Kenneth H., Michael Nelson L., Thomas Stephen J., Barouch Dan H., "Supplementary Materials for Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys", Science, American Association for the Advancement of Science, US, US , (20160909), vol. 353, no. 6304, doi:10.1126/science.aah6157, ISSN 0036-8075, pages 1 - 20, XP093145214
OPPOSITION- P. Abbink, R. A. Larocca, R. A. De La Barrera, C. A. Bricault, E. T. Moseley, M. Boyd, M. Kirilova, Z. Li, D. Nganga, O. Nanayakkara, R. Nityanandam, N. B. Mercado, E. N. Borducchi, A. Agarwal, A. L. Brinkman, C. Cabral, A. Chandrashekar, P. B. Giglio, D. Jetton, J. Jimenez, B. C. Lee, S. Mojta, K. Molloy, M. Shetty, G. H. Neubauer, K. E. Stephenson, J. P. S. Peron, P. M. D. A. Zanotto, J. Misamore, B. Finneyfrock, M. G. Lewis, G. Alter, K. Modjarrad, R. G. Jarman, K. H. Eckels, N. L. Michael, S. J. Thomas, D. H. Barouch, "Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys", Science, American Association for the Advancement of Science, US, US , (20160909), vol. 353, no. 6304, doi:10.1126/science.aah6157, ISSN 0036-8075, pages 1129 - 1132, XP055314484
OPPOSITION- C. Baronti, G. Piorkowski, R. N. Charrel, L. Boubis, I. Leparc-Goffart, X. De Lamballerie, "Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013", Genome Announcements, (20140605), vol. 2, no. 3, doi:10.1128/genomeA.00500-14, pages e00500 - e00500-14, XP055313805
OPPOSITION- B. D. Cox, R. A. Stanton, R. F. Schinazi, "Predicting Zika virus structural biology: Challenges and opportunities for intervention", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY., International Medical Press, GB, GB , (20150801), vol. 24, no. 3-4, doi:10.1177/2040206616653873, ISSN 0956-3202, pages 118 - 126, XP055328128
OPPOSITION- Musso Didier, "Zika Virus Transmission from French Polynesia to Brazil", EMERGING INFECTIOUS DISEASES, EID, ATLANTA, GA, US, US , (20151001), vol. 21, no. 10, doi:10.3201/eid2110.151125, ISSN 1080-6040, pages 1887 - 1887, XP093145227
OPPOSITION- Robert S. Lanciotti, Amy J. Lambert, Mark Holodniy, Sonia Saavedra, Leticia Del Carmen Castillo Signor, "Phylogeny of Zika Virus in Western Hemisphere, 2015", Emerging Infectious Diseases, (20160501), vol. 22, no. 5, doi:10.3201/eid2205.160065, pages 933 - 935, XP055684161
OPPOSITION- Lawrence Janice E., Steward Grieg F., "Purification of viruses by centrifugation", Manual of Aquatic Viral Ecology, American Society of Limnology and Oceanography , (20100101), pages 166 - 181, doi:10.4319/mave.2010.978-0-9845591-0-7.166, ISBN 978-0-9845591-0-7, XP093145249

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents